IFNL4 and Cirrhosis: Paradoxically, lacking IFNL4 is protective for relevant human viruses such as HCV [3]and SARS-COV-2 among others [20], whereas its presence is associated with reduced liver inflammation and cirrhosis in HCV-infected individuals [21,22].